UMP Healthcare Holdings Limited (UMP) has filed its monthly return for the period ended 31 August 2026, confirming a steady capital structure and full compliance with Hong Kong Stock Exchange public-float requirements.

Authorised and Issued Capital • Authorised share capital remained unchanged at 5.00 billion ordinary shares with a par value of HKD 0.001, equivalent to HKD 5.00 million. • Total issued shares stood at 810.96 million, identical to the July 2026 level; the company continues to hold zero treasury shares.

Equity Incentives and Potential Dilution • Under the terminated Post-IPO Share Option Scheme, 2.40 million options lapsed during the month, reducing outstanding options in that plan to 7.80 million. • No options were exercised, and no new shares were issued, leaving the share count unchanged and yielding zero proceeds from option exercises. • The 2023 Share Option Scheme remains unutilised, with headroom to issue or transfer up to 81.10 million shares—equivalent to roughly 10.00 % of current issued capital—should future grants be made. • After the lapses, outstanding options total 7.80 million shares, representing approximately 0.96 % of the company’s issued share base.

Other Capital Instruments • The filing reports no warrants, convertible securities, or other equity‐linked instruments outstanding. • There were no share repurchases, cancellations, or treasury-share transactions during the month.

Regulatory Compliance UMP affirmed that it met the Main Board’s minimum public-float threshold of 25 % as at 31 August 2026.

Overall, the August return signals capital stability, with no dilution events and a modest residual option overhang following the expiry of legacy awards.